Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association Between Enhanced Sympathetic Activity and Cardiometabolic Complications: a Cross-sectional Study on Predictive Power of 24-hour Urinary Metanephrines (SYMPACT)

NCT04495231 is registered in ClinicalTrials.gov with University of Turin, Italy as lead sponsor.

NCT NCT04495231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04495231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association Between Enhanced Sympathetic Activity and Cardiometabolic Complications: a Cross-sectional Study on Predictive Power of 24-hour Urinary Metanephrines (SYMPACT)
Lead sponsor
University of Turin, Italy
Phase
Observational
Overall status
Completed
Start date
September 1, 2007
Completion date
July 1, 2020
Enrollment
1,380 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

catecholamine; overproduction, catecholamine; secretion, diabetes mellitus, type 2, hypertension,essential, hypertensive heart disease, hypertensive kidney disease, metabolic syndrome